08:30
Welcome address
09:00

SESSION 2 – MYELOID MALIGNANCIES

Chairs: N-C. Gorin, Paris, France, A. Vazquez, Montevideo, Uruguay & L. Wang, Shanghai, China

  • 09.00 The place of Haplo-HSCT in myeloid malignancies in Europe A. Nagler, Tel Hashomer, Israel
  • 09.30 Haplo HSCT for AML R. Devillier, Marseille, France
  • 10.00 Acute leukemia relapse after Allo-HSCT: new insights in prevention and treatment I. Gojo, Baltimore, USA
  • 10.30 Haplo-HSCT for MDS D. Blaise, Marseille, France Download
11.00
Coffee break & exhibition visit
11:30

SESSION 3 – ALL

Chairs: J. El Cheikh, Beirut, Lebanon & T. Heinicke, Magdeburg, Germany

  • 11.30 R/R ALL best approach? Monoclonal antibodies E. Brissot, Paris, France Download
  • 12.0 R/R ALL best approach? Car T-cells J. Gauthier, Seattle, USA  Download
12:30
Lunch & exhibition visit
14:00

SESSION 4 – UPDATE ON HAPLO

Chairs: J-O. Bay, Clermont-Ferrand, France, S. Isaragrissil, Bangkok, Thailand & M. Ferrando, Montevideo, Uruguay

  • 14.00 Recent updates in Beijing Haplo-HSCT protocol X. J. Huang, Beijing, China Download
  • 14.30 Post-Transplant Cyclosphosphamide: GVL without GVHD? L. Luznik, Baltimore, USA
  • 15.00 Sequential targeted myeloablation for Myeloid malignancies B, Andersson Houston, USA Download
  • 15.30 Discussion
15:45

SESSION 5 – CAR T-CELLS (1)

Chairs: R. Gabus, Montevideo, Uruguay & F. Malard, Paris, France

  • 15.45 Present status of Car T-cells in Europe C. Chabannon, Marseille, France
  • 16.15 Car T-cells complications I. Yakoub-Agha, Lille, France
16:45
Coffee break & exhibition visit
17:15

SESSION 6 – CAR T CELLS (2)

Chairs: S. Fürst, Marseille, France, J. Gauthier, Seattle, USA & H. Yongxian, Hangzhou, China

  • 17.15 Car T-cells for multiple myeloma, M. Mohty, Paris, France
  • 17.45 Car T-cells: the Barcelona experience A. Urbano-Ispizua, Barcelona, Spain Download
  • 18.15 Can cellular immunotherapy be brought to patients living far from academic medical centers? F. Petersen, Boise, USA
  • 18.45 Discussion
20:30
Congress diner
Top